[Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma] [0.03%]
Ying Yao,Xiao-Lan Shi,Pan-Feng Wang et al.
Ying Yao et al.
Objective: To evaluate the feasibility of in-class transition（iCT） first-line bortezomib intolerance to carfilzomib in the treatment of patients with multiple myeloma（MM）. ...
Mu-Yun Wu,Jie Zhang,Na-Yan Yi et al.
Mu-Yun Wu et al.
Objective: To investigate the regulatory effect and molecular mechanism of lncRNA MALAT1 mediated by myeloma-derived exosomes on angiogenesis through in vitro and in vivo experiments. ...
[The Clinical Value of Plasma cfTFEB and miR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma] [0.03%]
Rong-Juan Zhang,Wei Wang,Ying Meng et al.
Rong-Juan Zhang et al.
Objective: To investigate the clinical value of plasma cfTFEB and miR-1246 in predicting the efficacy of bortezomib therapy in patients with multiple myeloma (MM). ...
[Analysis of Immunophenotype and Clinical Biological Characteristics of Mature T-Cell Lymphoma and Clonal T Cells of Undetermined Significance] [0.03%]
Zhao-Bo Li,Wei Cheng,Zhou-Feng Huang et al.
Zhao-Bo Li et al.
Objective: To analyze the immunophenotype and clinical characteristics of mature T-cell lymphoma (TCL) and clonal T cells of undetermined significance (T-CUS), and to explore the application value of flow cytometry in the...
[Expression of CD7 in Patients with Extranodal NK/T-Cell Lymphoma and Its Clinical Significance] [0.03%]
Yu-Jie Zhao,Qi-Qi Linghu,Jun-Peng Huang et al.
Yu-Jie Zhao et al.
Objective: To analyze the expression of CD7 in patients with extranodal NK/T-cell lymphoma (ENKTL) and its clinical significance. Methods: ...
[Comparison of Different Staging Systems of Extranodal NK/T Cell Lymphoma and Prognosis Analysis] [0.03%]
Feng-Qin Shi,Ming Zhao,Yuan Jia et al.
Feng-Qin Shi et al.
Objective: To compare the value of Ann Arbor stage and CA stage in predicting the survival of extranodal NK/T cell lymphoma (ENKTL), and to explore its clinical features and prognosis. ...
[Clinical Characteristics and Prognostic Analysis of Patients with EBV-Positive Diffuse Large B-Cell Lymphoma] [0.03%]
Feng-Ya Nan,Qi-Tang Huang,Na-Na Wang et al.
Feng-Ya Nan et al.
Objective: To explore the clinical features and prognosis of patients with Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL). Method...
[Prognostic Value of Prognostic Nutritional Index and Lymphocyte-to-Monocyte Ratio in Patients with Follicular Lymphoma] [0.03%]
Qi-Miao Shan,Dan Luo,Hua Ding et al.
Qi-Miao Shan et al.
Objective: To investigate the prognostic value of prognostic nutritional index (PNI) and lymphocyte-to-monocyte ratio (LMR) in patients with follicular lymphoma (FL). ...
[Clinical Analysis of Autologous Hematopoietic Stem Cell Transplantation in Treatment of Mantle Cell Lymphoma: a Multicenter Retrospective Study] [0.03%]
Long Pang,Ping Yang,Hong-Mei Jing
Long Pang
Objective: To investigate the efficacy and prognostic factors of autologous hematopoietic stem cell transplantation (ASCT) in the treatment of mantle cell lymphoma (MCL) in the real world. ...
[LncRNA PVT1 Regulates the MiR-20a-5p/HMGA2 Signaling Axis to Affect Proliferation and Apoptosis of Diffuse Large B-Cell Lymphoma Cells] [0.03%]
Xiao-Wei Xu,Wutikuer Adina,Hong-Li Zhang et al.
Xiao-Wei Xu et al.
Objective: To investigate the effect of long non-coding RNA (lncRNA) PVT1 on proliferation and apoptosis of diffuse large B-cell lymphoma (DLBCL) cells and the underlying mechanisms. ...